http://jcps.bjmu.edu.cn

中国药学(英文版) ›› 2019, Vol. 28 ›› Issue (5): 316-328.DOI: 10.5246/jcps.2019.05.031

• 【研究论文】 • 上一篇    下一篇

聚氨基胺-聚乙二醇-聚氨基胺共聚物的合成及其含阿霉素凝胶的制备与评价

李展韬1,2, 廖嫒2, 刘曼1,2, 张爽1,2, 冯振汉1, 王光雪2, 王景茹1,2, 徐美琦1,2, 李卓越1,2, 段晓川1,2, 郝艳丽1,2, 郑秀钗2, 李惠1, 纳沁2, 张华3, 刘碧林4, 张烜1,2*   

  1. 1. 北京大学医学部 药学院 分子药剂学与新释药系统北京市重点实验室, 北京 100191
    2. 北京大学医学部 药学院 药剂学系, 北京 100191
    3. 石河子大学 药学院 新疆植物药资源利用教育部重点实验室, 新疆 石河子 83200
    4. 重庆化工职业学院 制药工程学院, 重庆 401228
  • 收稿日期:2019-03-12 修回日期:2019-04-05 出版日期:2019-05-31 发布日期:2019-04-18
  • 通讯作者: Tel./Fax: +86-010-82805765, E-mail: xuanzhang@bjmu.edu.cn
  • 基金资助:

    The National Key Research and Development Program of China (Grant No. 2017YFA0205600), the National Natural Science Foundation of China (Grant No. 81773646), and the Innovation Team of the Ministry of Education (Grant No. BMU2017TD003).

Synthesis of poly(amidoamine)-poly(ethyleneglycol)-poly(amidoamine) and preparation of its hydrogel solution containing doxorubicin

Zhantao Li1,2, Ai Liao2, Man Liu1,2, Shuang Zhang1,2, Zhenhan Feng1, Guangxue Wang2, Jingru Wang1,2, Meiqi Xu1,2, Zhuoyue Li1,2, Xiaochuan Duan1,2, Yanli Hao1,2, Xiuchai Zheng2, Hui Li1, Qin Na2, Hua Zhang3, Bilin Liu4, Xuan Zhang1,2*   

  1. 1. Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing 100191, China    
    2. Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing 100191, China    
    3. Key Laboratory of Xinjiang Phytomedicine Resources and Utilization of Ministry of Education, School of Pharmacy, Shihezi University, Shihezi 832000, China
    4. College of Pharmaceutical Engineering, Chongqing Chemical Industry Vocational College, Chongqing 401228, China
  • Received:2019-03-12 Revised:2019-04-05 Online:2019-05-31 Published:2019-04-18
  • Contact: Tel./Fax: +86-010-82805765, E-mail: xuanzhang@bjmu.edu.cn
  • Supported by:

    The National Key Research and Development Program of China (Grant No. 2017YFA0205600), the National Natural Science Foundation of China (Grant No. 81773646), and the Innovation Team of the Ministry of Education (Grant No. BMU2017TD003).

摘要:

本研究通过选择适宜反应温度, 合成具有适宜pH/温度敏感性的聚氨基胺-聚乙二醇-聚氨基胺三嵌段共聚物(PAA-PEG-PAA), 制备PAA-PEG-PAA凝胶并对其性质进行考察; 选择阿霉素为模型药物, 制备含阿霉素的PAA-PEG-PAA凝胶并对其释放进行研究; 选择B16F10黑色素瘤细胞为模型, 考察含阿霉素的PAA-PEG-PAA凝胶的细胞药效。实验结果表明, 通过降低反应温度, 可降低PAA的分子量, 使PAA-PEG-PAA具有适宜的pH/温度敏感性。PAA-PEG-PAA凝胶的粘度具有浓度依赖和温度依赖的特征。在pH 6.07.4的范围内, PAA-PEG-PAA凝胶(12%, w/w)的液体-凝固相转变温度为3529 ºC。含阿霉素的PAA-PEG-PAA凝胶具有体外药物释放缓释的特征及体外抗肿瘤药效的作用。所制备的含阿霉素的PAA-PEG-PAA凝胶具有响应肿瘤酸性微环境及体温发生凝固、缓慢释放药物的特点, 推测经肿瘤内或者肿瘤旁注射后, 可发挥相应的抗肿瘤药效。

关键词: 聚氨基胺-聚乙二醇-聚氨基胺共聚物, pH/温度敏感聚合物, 凝胶, 阿霉素, B16F10细胞

Abstract:

Many pH- and temperature-responsive polymers have been designed for preparing hydrogel. In the present study, in order to decrease the pH sensitivity of reported poly(amidoamine)-poly(ethyleneglycol)-poly(amidoamine) (PAA1580-PEG4600-PAA1580), we designed and synthesized poly(amidoamine)-poly(ethyleneglycol)-poly(amidoamine) (PAA-PEG-PAA) with shorter length of PAA chain by decreasing reaction temperature for preparing PAA-PEG-PAA hydrogel solution containing doxorubicin (DOX). The PAA-PEG-PAA was synthesized via the Michael-addition polymerization. The characteristic of PAA-PEG-PAA was evaluated.The PAA-PEG-PAA hydrogel solution was prepared and investigated. DOX-loaded PAA-PEG-PAA hydrogel solution was prepared, and its in vitro DOX release and in vitro anti-tumor activity were evaluated. Our results indicated that the viscosity of PAA-PEG-PAA hydrogel solution was concentration- and temperature-dependent. The sol-gel transition temperature of PAA-PEG-PAA hydrogel solution (12 %, w/w) ranged from 35 to 29 ºC, and its pH ranged from 6.0 to 7.4. The released DOX from DOX-loaded PAA-PEG-PAA hydrogel showed sustained release characteristics. The in vitro anti-tumor activity of DOX-loaded PAA-PEG-PAA hydrogel was confirmed in B16F10 cell line. Considering the acidic tumor microenvironment, this DOX-loaded PAA-PEG-PAA hydrogel solution would be easy in situ administration for intra-tumor injection or para-tumor injection forming hydrogel at body temperature. We suggested that this DOX-loaded PAA-PEG-PAAhydrogel solution, if containing photothermal conversion agents, would have a potential further use for photothermal therapy.      

Key words: Poly(amidoamine)-poly(ethyleneglycol)-poly(amidoamine), pH- and temperature-responsive polymer, Hydrogel, Doxorubicin, B16F10 cells  

中图分类号: 

Supporting:

Methods

Drug release

As shown in Scheme 2, DOX loaded PAA-PEG-PAA hydrogel solution (3 mg/g) was loaded onto the upper insert of a transwell insert (the pore size of the transwell insert membrane was 8 μm). The transwell insert was incubated 30 min at 37 ºC for DOX loaded PAA-PEG-PAA hydrogel solution completed gelation. After that, the transwell was incubated in 1 mL of PBS at 42 ºC. At determined time, a volume of 200 μL release media were taken out and replaced with an equal volume of pre-warmed fresh PBS. The samples were diluted 10 times for determining the concentration of DOX with Spectrofluorophotometer (SHIMADZU, RF-5301PC).

 

The Cytotoxicity of DOX loaded PAA-PEG-PAA hydrogel

As shown in Scheme 3a, B16F10 cells were dispersed in FBS free DMEM and were added 200 μL onto the upper insert of the transwell inserts (the pore size of the transwell insert membrane was 8 μm), then the transwell inserts were placed in 48-well plates that was loaded with 1 mL of DMEM that contains FBS previously. Under the driven effect of FBS, cells migrant from the upper insert to the lower insert through the pores of the Polyester membrane of the transwell insert and adhere to the lower layer of the Polyester membrane after incubating at 37 °C for 48 h.

As shown in Scheme 3b, after cells are adhered on the lower insert membrane, a volume of 200 μL of DOX loaded PAA-PEG-PAA hydrogel solution was added onto the upper transwell insert. The transwell inserts were incubated 15 min at 42 ºC. After incubation, DOX loaded PAA-PEG-PAA hydrogel was removed and each insert was washed with PBS three times. After that, B16F10 cells were treated with Live-Dead Cell Staining Kit for 30 min. After removing the dyeing agent, transwell inserts were observed with Inverted Fluorescence Microscope (OLYMPUS, IX83). Living cells were observed with exciter filter BP530-550, barrier filter BA575-625. Dead cells were observed with exciter filter BP460-495, barrier filter BA510-550. GrapHical calculating software Image J was used to calculate the number of dead and living cells in the photos. Death cell ratio was calculated.

 

 ND: number of death cells;

 NL: number of living cells.

Negative control group was incubated with cell culture medium. Positive control group was incubated with saponin solution. Both negative and positive group was incubated at 37 ºC.

 

Result

Drug release

As shown in Figure S1, the released DOX from DOX loaded PAA-PEG-PAA hydrogel at 42 ºC was about 10.0 % at 144 h time point, slightly higher than that of at 37 ºC (7.8 %), also showing the sustained release characteristics.

The Cytotoxicity of DOX loaded PAA-PEG-PAA hydrogel

The calculated dead cell ratios were shown in Figure S21 The dead cell ratio in 0.5 mg/g, 1 mg/g and 3 mg/g DOX loaded PAA-PEG-PAA hydrogel groups at 42 ºC was about 64 %, 87 % and 86 %, respectively, significantly higher than that of control and blank gel groups, 1% and 3% (P<0.01). Also, the dead cell ratio in 0.5 mg/g, 1 mg/g and 3 mg/g DOX loaded PAA-PEG-PAA hydrogel groups at 42 ºC was higher than that of at 37 ºC.

Figure S1. The released DOX from DOX-loaded PAA-PEG-PAA hydrogel at 42 ºC.

 

Figure S2. The dead cell ratio of DOX-loaded PAA-PEG-PAA hydrogel at 42 ºC.